1201643-70-0 Usage
Uses
Used in Pharmaceutical Industry:
1-Phenylpyrazole-4-boronic acid is used as a key building block for the synthesis of various pharmaceuticals. Its boronic acid functionality allows for the formation of new carbon-carbon bonds through Suzuki coupling reactions, facilitating the creation of complex molecular structures with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 1-Phenylpyrazole-4-boronic acid serves as an essential component in the development of new agrochemicals. Its reactivity in cross-coupling reactions enables the synthesis of novel compounds with pesticidal or herbicidal properties, contributing to the advancement of crop protection strategies.
Used in Organic Synthesis:
1-Phenylpyrazole-4-boronic acid is employed as a versatile reagent in organic synthesis. Its unique properties, including the phenylpyrazole moiety and boronic acid functionality, make it suitable for a wide range of applications, such as the formation of new carbon-carbon bonds and the synthesis of complex organic molecules with diverse functionalities.
Check Digit Verification of cas no
The CAS Registry Mumber 1201643-70-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,6,4 and 3 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1201643-70:
(9*1)+(8*2)+(7*0)+(6*1)+(5*6)+(4*4)+(3*3)+(2*7)+(1*0)=100
100 % 10 = 0
So 1201643-70-0 is a valid CAS Registry Number.
1201643-70-0Relevant articles and documents
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITORS
-
, (2010/01/12)
Provided are compounds according to Formula (I), or stereoisomer, prodrug, polymorph, or pharmaceutically acceptable salt forms thereof, wherein X, Y, R1, R6 , R7, and R8 are as defined, which compounds are effective inhibitors of PI3-kinase and/or other medically and clinically relevant kinases. Also provided are pharmaceutical compositions and methods of using the compounds and compositions as PB -kinase and kinase inhibitors. More particularly, the compounds of the invention provide treatments and therapeutics for human diseases regulated by, or associated with, the activity of, PI3-kinases and/or protein kinases, or mutant or variant forms thereof.